US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 3.1475
  • +0.2291+7.85%
Trading Apr 26 09:37 ET
3.69MMarket Cap-242P/E (TTM)

Virpax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-22.46%16.94M
91.29%5.93M
-20.74%6.12M
-45.13%3.24M
-43.38%2.9M
81.66%21.85M
-24.74%3.1M
137.41%7.72M
156.08%5.9M
118.17%5.12M
Selling and administrative expenses
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-6.56%1.67M
54.21%11.08M
-26.47%1.74M
216.46%4.91M
33.01%2.65M
39.95%1.78M
-General and administrative expense
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-6.56%1.67M
54.21%11.08M
-26.47%1.74M
216.46%4.91M
33.01%2.65M
39.95%1.78M
Research and development costs
-52.45%5.12M
-19.30%1.1M
-46.68%1.5M
-60.39%1.29M
-63.02%1.24M
122.41%10.76M
-22.39%1.36M
65.18%2.81M
929.32%3.26M
210.83%3.34M
Operating profit
22.46%-16.94M
-91.29%-5.93M
20.74%-6.12M
45.13%-3.24M
43.38%-2.9M
-81.66%-21.85M
24.74%-3.1M
-137.41%-7.72M
-156.08%-5.9M
-118.17%-5.12M
Net non-operating interest income expense
Other net income (expense)
800.29%1.75M
1,093.69%1.37M
64.69%120.64K
554.07%126.72K
10,572.05%1.38M
212.26%194.41K
3,526.81%114.97K
16.42%73.25K
605.45%19.37K
-13.18K
Special income (charges)
--1.25M
----
----
----
--1.25M
----
----
----
----
----
-Less:Other special charges
---1.25M
----
----
----
---1.25M
----
----
----
----
----
Other non- operating income (expenses)
157.33%500.28K
6.45%122.39K
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
16.42%73.25K
605.45%19.37K
---13.18K
Income before tax
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
-115.91%-5.14M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
-115.91%-5.14M
Net income continuous Operations
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
-115.91%-5.14M
Minority interest income
Net income attributable to the parent company
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
-115.91%-5.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
-151.12%-5.88M
-115.91%-5.14M
Basic earnings per share
29.85%-12.97
-49.42%-3.87
21.54%-5.1
46.00%-2.7
70.45%-1.3
-2.15%-18.49
26.31%-2.59
-22.64%-6.5
-6.38%-5
26.67%-4.4
Diluted earnings per share
29.85%-12.97
-49.42%-3.87
21.54%-5.1
46.00%-2.7
70.45%-1.3
-2.15%-18.49
26.31%-2.59
-22.64%-6.5
-6.38%-5
26.67%-4.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -22.46%16.94M91.29%5.93M-20.74%6.12M-45.13%3.24M-43.38%2.9M81.66%21.85M-24.74%3.1M137.41%7.72M156.08%5.9M118.17%5.12M
Selling and administrative expenses 6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-6.56%1.67M54.21%11.08M-26.47%1.74M216.46%4.91M33.01%2.65M39.95%1.78M
-General and administrative expense 6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-6.56%1.67M54.21%11.08M-26.47%1.74M216.46%4.91M33.01%2.65M39.95%1.78M
Research and development costs -52.45%5.12M-19.30%1.1M-46.68%1.5M-60.39%1.29M-63.02%1.24M122.41%10.76M-22.39%1.36M65.18%2.81M929.32%3.26M210.83%3.34M
Operating profit 22.46%-16.94M-91.29%-5.93M20.74%-6.12M45.13%-3.24M43.38%-2.9M-81.66%-21.85M24.74%-3.1M-137.41%-7.72M-156.08%-5.9M-118.17%-5.12M
Net non-operating interest income expense
Other net income (expense) 800.29%1.75M1,093.69%1.37M64.69%120.64K554.07%126.72K10,572.05%1.38M212.26%194.41K3,526.81%114.97K16.42%73.25K605.45%19.37K-13.18K
Special income (charges) --1.25M--------------1.25M--------------------
-Less:Other special charges ---1.25M---------------1.25M--------------------
Other non- operating income (expenses) 157.33%500.28K6.45%122.39K64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K16.42%73.25K605.45%19.37K---13.18K
Income before tax 29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M-115.91%-5.14M
Income tax 0000000000
Net income 29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M-115.91%-5.14M
Net income continuous Operations 29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M-115.91%-5.14M
Minority interest income
Net income attributable to the parent company 29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M-115.91%-5.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M-151.12%-5.88M-115.91%-5.14M
Basic earnings per share 29.85%-12.97-49.42%-3.8721.54%-5.146.00%-2.770.45%-1.3-2.15%-18.4926.31%-2.59-22.64%-6.5-6.38%-526.67%-4.4
Diluted earnings per share 29.85%-12.97-49.42%-3.8721.54%-5.146.00%-2.770.45%-1.3-2.15%-18.4926.31%-2.59-22.64%-6.5-6.38%-526.67%-4.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg